Multiple sclerosis
Promising multiple sclerosis treatment targets immune cells to increase neuroprotection, study shows
Laquinimod skewed monocytes towards a regulatory phenotype and also acted via modulation of BDNF, which may contribute to neuroprotection in MS patients
Multiple sclerosis
Multiple sclerosis
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment